| P50 | author | Cornelia Weyand | Q87638981 |
| P2093 | author name string | Lan Shao | |
| | Jörg J Goronzy | |
| | Hiroshi Fujii | |
| P2860 | cites work | Telomerase modulates Wnt signalling by association with target gene chromatin | Q24310084 |
| | Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study | Q24812262 |
| | The influence of age on T cell generation and TCR diversity | Q28251818 |
| | ATR: an essential regulator of genome integrity | Q29547883 |
| | How shelterin protects mammalian telomeres | Q29615744 |
| | Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis | Q33646411 |
| | Why do people with rheumatoid arthritis still die prematurely? | Q33697879 |
| | Telomerase activation, cellular immortalization and cancer | Q34235187 |
| | ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks | Q34722732 |
| | Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes | Q34818981 |
| | Immunosenescence, autoimmunity, and rheumatoid arthritis | Q35198258 |
| | T cell homeostasis in patients with rheumatoid arthritis | Q35200330 |
| | Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks | Q35222177 |
| | Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration | Q35760179 |
| | Telomere erosion: a new link between HLA DR4 and rheumatoid arthritis? | Q35810876 |
| | Stem cell aging and autoimmunity in rheumatoid arthritis | Q35879516 |
| | Cancer-specific gene therapy. | Q36226789 |
| | Targeting telomerase. | Q36543162 |
| | The ATM-dependent DNA damage signaling pathway | Q36547714 |
| | T-cell-targeted therapies in rheumatoid arthritis | Q36577464 |
| | Perturbation of the T cell repertoire in rheumatoid arthritis | Q36735976 |
| | Mortality in established rheumatoid arthritis. | Q36942644 |
| | Fibroblasts as novel therapeutic targets in chronic inflammation | Q36983715 |
| | Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes | Q37073761 |
| | Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. | Q37089409 |
| | Telomerase insufficiency in rheumatoid arthritis | Q37132884 |
| | Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future. | Q37173126 |
| | B-lymphocyte contributions to human autoimmune disease | Q37211283 |
| | Atm and cellular response to DNA damage | Q37252382 |
| | Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis | Q37273198 |
| | Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer | Q37278036 |
| | Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis | Q37300823 |
| | Evidence that cytokines play a role in rheumatoid arthritis | Q37316594 |
| | Chromatin recruitment of DNA repair proteins: lessons from the fanconi anemia and double-strand break repair pathways. | Q37321372 |
| | T cells in rheumatoid arthritis | Q37324840 |
| | Dynamic interactions between T cells and dendritic cells and their derived cytokines/chemokines in the rheumatoid synovium | Q37324843 |
| | Immune receptor signaling, aging and autoimmunity | Q37344399 |
| | CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity | Q37354502 |
| | The ageing immune system: is it ever too old to become young again? | Q37357018 |
| | Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis | Q41304856 |
| | The genetic defect in ataxia-telangiectasia | Q41464274 |
| | Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes | Q42628689 |
| | Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period | Q44506234 |
| | Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis. | Q52009888 |
| | Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H | Q71257873 |
| | Homeostatic control of T-cell generation in neonates | Q73316204 |
| | Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis | Q80624459 |
| | Rheumatoid arthritis | Q81574136 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 583-588 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Nature Reviews Rheumatology | Q2107227 |
| P1476 | title | Rejuvenating the immune system in rheumatoid arthritis | |
| P478 | volume | 5 | |